Genflow Biosciences PLC (LSE: GENF), a leading company in the field of longevity, has revealed plans to reorganize its primary board of directors and scientific advisory board (SAB) in order
Genflow Biosciences PLC (LSE: GENF), a leading company in the field of longevity, has revealed plans to reorganize its primary board of directors and scientific advisory board (SAB) in order
Running an efficient and cost-effective investment business is becoming increasingly complex as our industry changes rapidly. To maximize operational efficiency, your company must have a streamlined accounting process. As any
The details of creditors who lost nearly £187m due to the collapse of Made.com, ranging from a Thurrock council owed payment to an east London art shop that left out
On 31 October, the Board of MDL, MADE’s operating subsidiary, notified MADE that it had resolved to file notice of its intention to appoint administrators.
Made.com’s founder has failed to seize control of the online retailer, which is on the verge of going bankrupt.
The Board of MADE is pleased to provide an update on its formal sale process.
Strategic Review, Formal Sale Process and Commencement of Offer Period (“Strategic Review”)
Genflow Biosciences Plc (“Genflow” or ” the Company”), a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of ageing and diseases associated with